A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bile Duct Cancer
- Liver Cancer
- Pancreas Cancer
- Stomach Cancer
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 25 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04014478
- Collaborators
- Not Provided
- Investigators
- Study Chair: Gao-Jun Teng, MD Southeast University Affiliated Zhongda Hospital Principal Investigator: zhong-Min Wang, MD Shanghai JiaoTong University Affiliated RuiJin Hospital Principal Investigator: Jian Wang, MD Beijing University Affiliated the First Hospital Principal Investigator: Wen-Tao Li, MD Fudan University Affiliated Cancer Hospital Principal Investigator: Chuan-Sheng Zheng, MD HuaZhong University of Science and Technology Affiliated Union Hospital Principal Investigator: Wei-Fu Lv, MD China University of Science and Technology Affiliated the First Hospital Principal Investigator: Jun-Hui Sun, MD Zhejiang University Affiliated the First Hospital Principal Investigator: Hao Xu, MD XuZhou Medical College Affiliated Hospital Principal Investigator: Ming Huang, MD Yunnan Provincial Cancer Hospital Principal Investigator: Li-Gong Lu, MD The People's Hospital of Zhuhai City Principal Investigator: Jian-Song Ji, MD The Central Hospital of Lishui City